We are delighted to share that our December 2025 review in the journal Frontiers in Nutrition has now been read almost 5,000 times. The paper, "Nutritional strategies in supporting immune checkpoint inhibitor, PI3K inhibitor, and tyrosine kinase inhibitor cancer therapies", brings together the current evidence on how thoughtful, individualised nutrition can support some of the most important modern cancer treatments. Dr Nina Fuller-Shavel led this work as part of our research programme at Synthesis Clinic, and the response from clinicians and researchers around the world has been genuinely encouraging.

In this blog Dr Nina summarises the review in plain language, explain what these treatments are, and sets out some practical, safe steps that people receiving them can consider, always in partnership with their own medical team.

Our Director, Dr Nina Fuller-Shavel, has recently co-authored a review paper with Dr Jonathan Krell, consultant medical oncologist at Imperial College London and HCA, on ‘Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours’. In this blog Dr Nina summarises the paper, including some key actions people treated with immune checkpoint inhibitors can take to support their treatment and wellbeing.

Dr Nina Fuller-Shavel reflects on 2023, including her work as the Director and Head of Integrative Cancer Care at Synthesis Clinic, the launch of the Oncio app, events, lectures, two new postgraduate degrees and integrative oncology publications.